Detalhe da pesquisa
1.
Extended characterization of anti-CD19 CAR T cell products manufactured at the point of care using the CliniMACS Prodigy system: comparison of donor sources and process duration.
Cytotherapy
; 2024 Mar 02.
Artigo
Inglês
| MEDLINE | ID: mdl-38493403
2.
Mismatched related vs matched unrelated donors in TCRαß/CD19-depleted HSCT for primary immunodeficiencies.
Blood
; 134(20): 1755-1763, 2019 11 14.
Artigo
Inglês
| MEDLINE | ID: mdl-31558465
3.
Control of graft-versus-host disease with rabbit anti-thymocyte globulin, rituximab, and bortezomib in TCRαß/CD19-depleted graft transplantation for leukemia in children: a single-center retrospective analysis of two GVHD-prophylaxis regimens.
Pediatr Transplant
; 24(1): e13594, 2020 02.
Artigo
Inglês
| MEDLINE | ID: mdl-31680369
4.
αß T Cell-Depleted Haploidentical Hematopoietic Stem Cell Transplantation without Antithymocyte Globulin in Children with Chemorefractory Acute Myelogenous Leukemia.
Biol Blood Marrow Transplant
; 25(5): e179-e182, 2019 05.
Artigo
Inglês
| MEDLINE | ID: mdl-30677509
5.
Impact of Natural Killer Cell-Associated Factors on Acute Leukemia Outcomes after Haploidentical Hematopoietic Stem Cell Transplantation with αß T Cell Depletion in a Pediatric Cohort.
Transplant Cell Ther
; 30(4): 435.e1-435.e12, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38278183
6.
Serotherapy-Free Regimen Improves Non-Relapse Mortality and Immune Recovery Among the Recipients of αß TCell-Depleted Haploidentical Grafts: Retrospective Study in Childhood Leukemia.
Transplant Cell Ther
; 27(4): 330.e1-330.e9, 2021 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33836878
7.
T-cell tracking, safety, and effect of low-dose donor memory T-cell infusions after αß T cell-depleted hematopoietic stem cell transplantation.
Bone Marrow Transplant
; 56(4): 900-908, 2021 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33203952
8.
Safety and efficacy of the low-dose memory (CD45RA-depleted) donor lymphocyte infusion in recipients of αß T cell-depleted haploidentical grafts: results of a prospective randomized trial in high-risk childhood leukemia.
Bone Marrow Transplant
; 56(7): 1614-1624, 2021 07.
Artigo
Inglês
| MEDLINE | ID: mdl-33594278
9.
Multiple site place-of-care manufactured anti-CD19 CAR-T cells induce high remission rates in B-cell malignancy patients.
Nat Commun
; 12(1): 7200, 2021 12 10.
Artigo
Inglês
| MEDLINE | ID: mdl-34893603
10.
Low-dose donor memory T-cell infusion after TCR alpha/beta depleted unrelated and haploidentical transplantation: results of a pilot trial.
Bone Marrow Transplant
; 53(3): 264-273, 2018 03.
Artigo
Inglês
| MEDLINE | ID: mdl-29269793
11.
Haploidentical donor-derived memory CAR T cells: first in human experience and in vitro correlative study.
Blood Adv
; 6(19): 5582-5588, 2022 10 11.
Artigo
Inglês
| MEDLINE | ID: mdl-35446932
12.
Outcome of αß T cell-depleted transplantation in children with high-risk acute myeloid leukemia, grafted in remission.
Bone Marrow Transplant
; 55(1): 256-259, 2020 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30988381